Distinct proliferative and transcriptional effects of the D-type cyclins in vivo
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The D-type cyclins (D1, D2 and D3) are components of the cell cycle machinery and govern progression through G(1) phase in response to extracellular signals. Although these proteins are highly homologous and conserved in evolution, they contain distinct structural motifs and are differentially regulated in various cell types. Cyclin D1 appears to play a role in many different types of cancer, whereas cyclins D2 and D3 are less frequently associated with malignancy. In this study, we transiently expressed cyclin D1, D2 or D3 in hepatocytes and analyzed transcriptional networks regulated by each. All three D-type cyclins promoted robust hepatocyte proliferation and marked liver growth, although cyclin D3 stimulated less DNA synthesis than D1 or D2. Accordingly, the three D-type cyclins similarly activated genes associated with cell division. Cyclin D1 regulated transcriptional pathways involved in the metabolism of carbohydrates, lipids, amino acids, and other substrates, whereas cyclin D2 did not regulate these pathways despite having an equivalent effect on proliferation. Comparison of transcriptional profiles following 70% partial hepatectomy and cyclin D1 transduction revealed a highly significant overlap, suggesting that cyclin D1 may regulate diverse cellular processes in the regenerating liver. In summary, these studies provide the first comparative analysis of the transcriptional networks regulated by the D-type cyclins and provide insight into novel functions of these key cell cycle proteins. Further study of the unique targets of cyclin D1 should provide further insight into its prominent role in proliferation, growth and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fausto, N., Campbell, J. S., & Riehle, K. J. (2006) · Hepatology · doi:10.1002/hep.20969 · Cited by 1,378
Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6
Malumbres, M., Sotillo, R., Santamarı́a, D., Galán, J., Cerezo, A., Ortega, S., Dubus, P., & Barbacid, M. (2004) · Cell · doi:10.1016/j.cell.2004.08.002 · Cited by 793
Mouse development and cell proliferation in the absence of D-cyclins
Kozar, K., Ciemerych, M. A., Rebel, V. I., Shigematsu, H., Zagozdzon, A., Sicinska, E., Geng, Y., Yu, Q., Bhattacharya, S., Bronson, R. T., et al. (2004) · Cell · doi:10.1016/j.cell.2004.07.025 · Cited by 647
Differential regulation of cyclins D1 and D3 in hepatocyte proliferation
Rickheim, D. G., Nelsen, C. J., Fassett, J. T., Timchenko, N. A., Hansen, L. K., & Albrecht, J. H. (2002) · Hepatology · doi:10.1053/jhep.2002.33996 · Cited by 112
Self-citation
Cited by
Cyclin D as a therapeutic target in cancer
Musgrove, E. A., Caldon, C. E., Barraclough, J., Stone, A., & Sutherland, R. L. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3090 · Cited by 1,370
Liver regeneration: biological and pathological mechanisms and implications
Michalopoulos, G. K., & Bhushan, B. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0342-4 · Cited by 998
Hepatostat: Liver regeneration and normal liver tissue maintenance
Michalopoulos, G. K. (2017) · Hepatology · doi:10.1002/hep.28988 · Cited by 444
“Cyclin D1 activation and migration to the nucleus commits hepatocytes to DNA synthesis (17).”
Cell cycle regulation and anticancer drug discovery
Jingwen, B., Yaochen, L., & Guojun, Z. (2017) · Cancer Biology & Medicine · doi:10.20892/j.issn.2095-3941.2017.0033 · Cited by 302
The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells
Bruschi, F. V., Claudel, T., Tardelli, M., Caligiuri, A., Stulnig, T. M., Marra, F., & Trauner, M. (2017) · Hepatology · doi:10.1002/hep.29041 · Cited by 268
Preziosi, M., Okabe, H., Poddar, M., Singh, S., & Monga, S. P. (2018) · Hepatology Communications · doi:10.1002/hep4.1196 · Cited by 135
“Because cyclin-D1 has functions beyond proliferation, such as in metabolism, estrogen-dependent cyclin-D1 may be performing additional functions in female livers.((32)) An important unanswered question that requires further investigation is the molecular basis of regeneration in the three genotypes that lack “physiolo…”
BackgroundLiu, B., Bell, A. W., Paranjpe, S., Bowen, W. C., Khillan, J. S., Luo, J.-H., Mars, W. M., & Michalopoulos, G. K. (2010) · Hepatology · doi:10.1002/hep.23794 · Cited by 77
“The changes associated with cell cycle–related genes after PHx are easier to correlate with the observed suppression of liver regeneration, especially with respect to cyclins A and D1, which are well known to be associated with the entry of hepatocytes into the S-phase of the cycle.(32) The observed increase in C/EBPa…”
BackgroundCREBZF as a Key Regulator of STAT3 Pathway in the Control of Liver Regeneration in Mice
Hu, Z., Han, Y., Liu, Y., Zhao, Z., Ma, F., Cui, A., Zhang, F., Liu, Z., Xue, Y., Bai, J., et al. (2020) · Hepatology · doi:10.1002/hep.30919 · Cited by 65
“Given that activation of cell cycle plays an important role in the stimulation of robust hepatocyte proliferation during liver regeneration,(2,29) expression levels of checkpoint components of the cell cycle machinery that control progression through various cell cycle phases were measured.”
BackgroundTrinh, V. Q.-H., Lee, T.-F., Lemoinne, S., Ray, K. C., Ybanez, M. D., Tsuchida, T., Carter, J. K., Agudo, J., Brown, B. D., Akat, K. M., et al. (2023) · Science Signaling · doi:10.1126/scisignal.adf6696 · Cited by 45
“Central to this finding is cyclin D1 (CCND1), a cell cycle protein that promotes progression from the G1 to the S phase (14).”
Background
Metadata
- Authors
- Mullany, L. K., White, P., Hanse, E. A., Nelsen, C. J., Goggin, M. M., Mullany, J. E., Anttila, C. K., Greenbaum, L. E., Kaestner, K. H., & Albrecht, J. H.
- Venue
- Cell Cycle
- Publisher
- Informa UK Limited
- Published
- 2008-07-15
- Volume
- 7
- Issue
- 14
- Pages
- 2215-2224
- ISSN
- 1538-4101 (ISSN-L)
- 1551-4005
- OpenAlex
- W2014016589
- Cited by
- 80
- References
- 4
- FWCI
- 3.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.